1 Market Overview
1.1 Asthma Therapeutic Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Asthma Therapeutic Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Long-Term Control Medications
1.2.3 Quick-Relief Medications
1.3 Market Analysis by Application
1.3.1 Overview: Global Asthma Therapeutic Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Online Pharmacy
1.3.3 Offline Pharmacy
1.4 Global Asthma Therapeutic Drug Market Size & Forecast
1.4.1 Global Asthma Therapeutic Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Asthma Therapeutic Drug Sales in Volume (2017-2028)
1.4.3 Global Asthma Therapeutic Drug Price (2017-2028)
1.5 Global Asthma Therapeutic Drug Production Capacity Analysis
1.5.1 Global Asthma Therapeutic Drug Total Production Capacity (2017-2028)
1.5.2 Global Asthma Therapeutic Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Asthma Therapeutic Drug Market Drivers
1.6.2 Asthma Therapeutic Drug Market Restraints
1.6.3 Asthma Therapeutic Drug Trends Analysis
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Asthma Therapeutic Drug Product and Services
2.1.4 Abbott Asthma Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Akorn
2.2.1 Akorn Details
2.2.2 Akorn Major Business
2.2.3 Akorn Asthma Therapeutic Drug Product and Services
2.2.4 Akorn Asthma Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Asthma Therapeutic Drug Product and Services
2.3.4 AbbVie Asthma Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca Asthma Therapeutic Drug Product and Services
2.4.4 AstraZeneca Asthma Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Asthma Therapeutic Drug Product and Services
2.5.4 Boehringer Ingelheim Asthma Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Cipla
2.6.1 Cipla Details
2.6.2 Cipla Major Business
2.6.3 Cipla Asthma Therapeutic Drug Product and Services
2.6.4 Cipla Asthma Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business
2.7.3 GSK Asthma Therapeutic Drug Product and Services
2.7.4 GSK Asthma Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Asthma Therapeutic Drug Product and Services
2.8.4 Merck Asthma Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan Asthma Therapeutic Drug Product and Services
2.9.4 Mylan Asthma Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Asthma Therapeutic Drug Product and Services
2.10.4 Novartis Asthma Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer Asthma Therapeutic Drug Product and Services
2.11.4 Pfizer Asthma Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Roche
2.12.1 Roche Details
2.12.2 Roche Major Business
2.12.3 Roche Asthma Therapeutic Drug Product and Services
2.12.4 Roche Asthma Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Teva
2.13.1 Teva Details
2.13.2 Teva Major Business
2.13.3 Teva Asthma Therapeutic Drug Product and Services
2.13.4 Teva Asthma Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Vectura
2.14.1 Vectura Details
2.14.2 Vectura Major Business
2.14.3 Vectura Asthma Therapeutic Drug Product and Services
2.14.4 Vectura Asthma Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Asthma Therapeutic Drug Breakdown Data by Manufacturer
3.1 Global Asthma Therapeutic Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Asthma Therapeutic Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Asthma Therapeutic Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Asthma Therapeutic Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Asthma Therapeutic Drug Manufacturer Market Share in 2021
3.5 Global Asthma Therapeutic Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Asthma Therapeutic Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Asthma Therapeutic Drug Market Size by Region
4.1.1 Global Asthma Therapeutic Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Asthma Therapeutic Drug Revenue by Region (2017-2028)
4.2 North America Asthma Therapeutic Drug Revenue (2017-2028)
4.3 Europe Asthma Therapeutic Drug Revenue (2017-2028)
4.4 Asia-Pacific Asthma Therapeutic Drug Revenue (2017-2028)
4.5 South America Asthma Therapeutic Drug Revenue (2017-2028)
4.6 Middle East and Africa Asthma Therapeutic Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Asthma Therapeutic Drug Sales in Volume by Type (2017-2028)
5.2 Global Asthma Therapeutic Drug Revenue by Type (2017-2028)
5.3 Global Asthma Therapeutic Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Asthma Therapeutic Drug Sales in Volume by Application (2017-2028)
6.2 Global Asthma Therapeutic Drug Revenue by Application (2017-2028)
6.3 Global Asthma Therapeutic Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Asthma Therapeutic Drug Sales by Type (2017-2028)
7.2 North America Asthma Therapeutic Drug Sales by Application (2017-2028)
7.3 North America Asthma Therapeutic Drug Market Size by Country
7.3.1 North America Asthma Therapeutic Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Asthma Therapeutic Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Asthma Therapeutic Drug Sales by Type (2017-2028)
8.2 Europe Asthma Therapeutic Drug Sales by Application (2017-2028)
8.3 Europe Asthma Therapeutic Drug Market Size by Country
8.3.1 Europe Asthma Therapeutic Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Asthma Therapeutic Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Asthma Therapeutic Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Asthma Therapeutic Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Asthma Therapeutic Drug Market Size by Region
9.3.1 Asia-Pacific Asthma Therapeutic Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Asthma Therapeutic Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Asthma Therapeutic Drug Sales by Type (2017-2028)
10.2 South America Asthma Therapeutic Drug Sales by Application (2017-2028)
10.3 South America Asthma Therapeutic Drug Market Size by Country
10.3.1 South America Asthma Therapeutic Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Asthma Therapeutic Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Asthma Therapeutic Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Asthma Therapeutic Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Asthma Therapeutic Drug Market Size by Country
11.3.1 Middle East & Africa Asthma Therapeutic Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Asthma Therapeutic Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Asthma Therapeutic Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Asthma Therapeutic Drug
12.3 Asthma Therapeutic Drug Production Process
12.4 Asthma Therapeutic Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Asthma Therapeutic Drug Typical Distributors
13.3 Asthma Therapeutic Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
世界の喘息治療薬市場2022年：長期管理薬、速効薬 |
| 【英語タイトル】Global Asthma Therapeutic Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 | |
 | ・商品コード：GIR22NO19165 ・発行会社（調査会社）：GlobalInfoResearch ・発行日：2022年11月2日（※2025年版があります。お問い合わせください。） ・ページ数：103 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（注文後2-3日） ・調査対象地域：グローバル ・産業分野：医薬品 |
| Single User（1名様閲覧用） | USD3,480 ⇒換算￥528,960 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD5,220 ⇒換算￥793,440 | 見積依頼/購入/質問フォーム |
| Corporate User（同一法人内共有可） | USD6,960 ⇒換算￥1,057,920 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 喘息治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の喘息治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 喘息治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・長期管理薬、速効薬 用途別セグメントは次のように区分されます。 ・オンライン薬局、オフライン薬局 世界の喘息治療薬市場の主要な市場プレーヤーは以下のとおりです。 ・Abbott、Akorn、AbbVie、AstraZeneca、Boehringer Ingelheim、Cipla、GSK、Merck、Mylan、Novartis、Pfizer、Roche、Teva、Vectura 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、喘息治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な喘息治療薬メーカーの企業概要、2019年～2022年までの喘息治療薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な喘息治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別喘息治療薬の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの喘息治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での喘息治療薬市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および喘息治療薬の産業チェーンを掲載しています。 ・第13、14、15章では、喘息治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 喘息治療薬の概要 - 種類別分析（2017年vs2021年vs2028年）：長期管理薬、速効薬 - 用途別分析（2017年vs2021年vs2028年）：オンライン薬局、オフライン薬局 - 世界の喘息治療薬市場規模・予測 - 世界の喘息治療薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Abbott、Akorn、AbbVie、AstraZeneca、Boehringer Ingelheim、Cipla、GSK、Merck、Mylan、Novartis、Pfizer、Roche、Teva、Vectura ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：長期管理薬、速効薬 ・用途別分析2017年-2028年：オンライン薬局、オフライン薬局 ・喘息治療薬の北米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・喘息治療薬のヨーロッパ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・喘息治療薬のアジア市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・喘息治療薬の南米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・喘息治療薬の中東・アフリカ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Asthma Therapeutic Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Asthma Therapeutic Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Online Pharmacy accounting for % of the Asthma Therapeutic Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Long-Term Control Medications segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Asthma Therapeutic Drug include Abbott, Akorn, AbbVie, AstraZeneca, and Boehringer Ingelheim, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Asthma Therapeutic Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Long-Term Control Medications
Quick-Relief Medications
Market segment by Application can be divided into
Online Pharmacy
Offline Pharmacy
The key market players for global Asthma Therapeutic Drug market are listed below:
Abbott
Akorn
AbbVie
AstraZeneca
Boehringer Ingelheim
Cipla
GSK
Merck
Mylan
Novartis
Pfizer
Roche
Teva
Vectura
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Asthma Therapeutic Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Asthma Therapeutic Drug, with price, sales, revenue and global market share of Asthma Therapeutic Drug from 2019 to 2022.
Chapter 3, the Asthma Therapeutic Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Asthma Therapeutic Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Asthma Therapeutic Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Asthma Therapeutic Drug.
Chapter 13, 14, and 15, to describe Asthma Therapeutic Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
| ★調査レポート[世界の喘息治療薬市場2022年：長期管理薬、速効薬] (コード：GIR22NO19165)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の喘息治療薬市場2022年：長期管理薬、速効薬]についてメールでお問い合わせ |
